Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

(1) Ghent University,Ghent,Belgium

(2) Ghent University Hospital,Ghent,Belgium

(3) AZ Groeninge,Kortrijk,Belgium

(4) AZ Sint-Lucas Ghent,Ghent,Belgium

(5) University Hospital Antwerp - UZA,Antwerp,Belgium

This item was part of the New ways to predict response in IBD session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019